[Development and application of a method for molecular diagnosis of 21-hydroxylase deficiency]

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2013 Feb;30(1):49-54. doi: 10.3760/cma.j.issn.1003-9406.2013.01.012.
[Article in Chinese]

Abstract

Objective: To develop a method for elucidating genetic basis of 21-hydroxylase deficiency.

Methods: Sanger sequencing of entire 21-hydroxylase coding gene CYP21A2 was carried out to detect point mutations, and multiplex ligation-dependent probe amplification (MLPA) and locus-specific PCR/enzyme restriction method were used to detect large deletions and conversion mutations.

Results: Nine children were analyzed. Point mutations of the CYP21A2 gene have been identified as: IVS2 13A/C>G (9 alleles), p.Arg356Trp (1 allele), Cluster E6 (1 allele), p.Gln318X (1 allele), and Prom conv (1 allele). While the former 4 mutations are pathogenic, the role of Prom conv mutation in the pathogenesis was uncertain. Three cases had entire CYP21A2 gene deletions (3 alleles), three had CYP21A1P/CYP21A2 chimeric mutations (3 alleles). The genotypes of all patients were determined. And all of the mutations were inherited from parents.

Conclusion: A rational method for detecting point mutations and large deletions/conversions of CYP21A2 gene has been established.

MeSH terms

  • Adrenal Hyperplasia, Congenital / diagnosis*
  • Adrenal Hyperplasia, Congenital / genetics*
  • Alleles
  • Base Sequence
  • Child
  • Child, Preschool
  • Female
  • Gene Order
  • Genotype
  • Humans
  • Infant
  • Male
  • Multiplex Polymerase Chain Reaction
  • Steroid 21-Hydroxylase / genetics

Substances

  • CYP21A2 protein, human
  • Steroid 21-Hydroxylase

Supplementary concepts

  • Congenital adrenal hyperplasia due to 21 hydroxylase deficiency